SiNAPTIC Technologies Gets Grant to Advance Ceramic AM
This project will improve customer access to additively manufactured silicon nitride for medical and industrial applications.
June 18, 2024
SiNAPTIC Technologies, a contract manufacturer that is dedicated to the development and on-demand manufacturing of additive manufactured technical ceramics, has been awarded an Early-Stage Capital and Retention Grant through the Colorado Office of Economic Development and International Trade (OEDIT) Advanced Industries Accelerator program. This funding will help further the development of SiNAPTIC's printable silicon nitride slurry through testing toward the submission of an FDA Master File.
“SiNAPTIC Technologies is passionate about serial production and contract manufacturing of technical ceramics to help customers overcome product design issues associated with traditional ceramic manufacturing. Upon the completion of this grant-funded project, we will attract innovators wanting to license our silicon nitride slurry to develop their own medical products for the regulatory benefits offered by the Master File,” says SiNAPTIC CEO Bryan Scheer, MD.
The Early-Stage Capital and Retention Grant supports businesses commercializing technologies that will be created or manufactured in Colorado. These grants promote the growth and sustainability of advanced industries across the state.
SiNAPTIC Technologies was awarded $250,000 to conduct biocompatibility testing and process validation activities toward the submission of an FDA Master File for its printable silicon nitride slurry. An additional portion of the awarded funds will be used to hire and train three Colorado-based technical personnel that will help development of the Master File and production ramp-up. This project will improve customer access to additively manufactured silicon nitride for medical and industrial applications.
“SiNAPTIC is comprised of two business divisions, SiNAPTIC Technologies and SiNAPTIC Surgical, with each having a different focus. SiNAPTIC Technologies provides R&D and prototyping through scaled OEM manufacturing, whereas SiNAPTIC Surgical is focused on becoming an FDA registered, fully integrated original medical device producer,” says Hugh Roberts, chief operating officer of SiNAPTIC. SiNAPTIC Technologies responds to inquiries from OEMs across various industries to support with ceramic 3D printing services, from design, development, and prototyping to serial production at industrial scale.
Sources: Press materials received from the company and additional information gleaned from the company’s website.
Subscribe to our FREE magazine,
FREE email newsletters or both!About the Author
DE EditorsDE’s editors contribute news and new product announcements to Digital Engineering.
Press releases may be sent to them via [email protected].